Peter Altman, President and CEO at BioCardia, Inc. (BCDA), bought 5,400 shares at $0.93 ($5K) on 2026-08-17, disclosed to the SEC on 2026-08-18.
Open-market purchase of $5k BCDA by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BCDA | BUY | 2026-09-04 | $872 | — | Filing → |
| BCDA | BUY | 2026-08-13 | $2K | — | Filing → |
| BCDA | BUY | 2026-07-29 | $4K | — | Filing → |